Literature DB >> 29849040

Congenital chloride diarrhea needs to be distinguished from Bartter and Gitelman syndrome.

Natsuki Matsunoshita1,2, Kandai Nozu3, Masahide Yoshikane4, Azusa Kawaguchi5, Naoya Fujita5, Naoya Morisada1, Shingo Ishimori1, Tomohiko Yamamura1, Shogo Minamikawa1, Tomoko Horinouchi1, Keita Nakanishi1, Junya Fujimura1, Takeshi Ninchoji1, Ichiro Morioka1, Hiroaki Nagase1, Mariko Taniguchi-Ikeda1, Hiroshi Kaito1, Kazumoto Iijima1.   

Abstract

Pseudo-Bartter/Gitelman syndrome (p-BS/GS) encompasses a clinically heterogeneous group of inherited or acquired disorders similar to Bartter syndrome (BS) or Gitelman syndrome (GS), both renal salt-losing tubulopathies. Phenotypic overlap frequently occurs between p-BS/GS and BS/GS, which are difficult to diagnose based on their clinical presentation and require genetic tests for accurate diagnosis. In addition, p-BS/GS can occur as a result of other inherited diseases such as cystic fibrosis, autosomal dominant hypocalcemia, Dent disease, or congenital chloride diarrhea (CCD). However, the detection of the variants in genes other than known BS/GS-causing genes by conventional Sanger sequencing requires substantial time and resources. We studied 27 cases clinically diagnosed with BS/GS, but with negative genetic tests for known BS/GS genes. We conducted targeted sequencing for 22 genes including genes responsible for tubulopathies and other inherited diseases manifesting with p-BS/GS symptoms. We detected the SLC26A3 gene variants responsible for CCD in two patients. In Patient 1, we found the SLC26A3 compound heterozygous variants: c.354delC and c.1008insT. In Patient 2, we identified the compound heterozygous variants: c.877G > A, p.(Glu293Lys), and c.1008insT. Our results suggest that a comprehensive genetic screening system using targeted sequencing is useful for the diagnosis of patients with p-BS/GS with alternative genetic origins.

Entities:  

Mesh:

Year:  2018        PMID: 29849040     DOI: 10.1038/s10038-018-0470-7

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  25 in total

1.  Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.

Authors:  D B Simon; R S Bindra; T A Mansfield; C Nelson-Williams; E Mendonca; R Stone; S Schurman; A Nayir; H Alpay; A Bakkaloglu; J Rodriguez-Soriano; J M Morales; S A Sanjad; C M Taylor; D Pilz; A Brem; H Trachtman; W Griswold; G A Richard; E John; R P Lifton
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

2.  Pseudo-Bartter's syndrome in cystic fibrosis.

Authors:  J D Kennedy; R Dinwiddie; C Daman-Willems; M J Dillon; D J Matthew
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

3.  Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK.

Authors:  D B Simon; F E Karet; J Rodriguez-Soriano; J H Hamdan; A DiPietro; H Trachtman; S A Sanjad; R P Lifton
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

4.  Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel.

Authors:  Takayasu Mori; Kazuyoshi Hosomichi; Motoko Chiga; Shintaro Mandai; Hirofumi Nakaoka; Eisei Sohara; Tomokazu Okado; Tatemitsu Rai; Sei Sasaki; Ituro Inoue; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2016-02-26       Impact factor: 2.801

5.  Congenital chloride diarrhea, an autosomal recessive disease. Genetic study of 14 Finnish and 12 other families.

Authors:  R Norio; J Perheentupa; K Launiala; N Hallman
Journal:  Clin Genet       Date:  1971       Impact factor: 4.438

Review 6.  Update on SLC26A3 mutations in congenital chloride diarrhea.

Authors:  Satu Wedenoja; Elina Pekansaari; Pia Höglund; Siru Mäkelä; Christer Holmberg; Juha Kere
Journal:  Hum Mutat       Date:  2011-06-07       Impact factor: 4.878

7.  Congenital chloride diarrhoea. Clinical analysis of 21 Finnish patients.

Authors:  C Holmberg; J Perheentupa; K Launiala; N Hallman
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

Review 8.  Antenatal differential diagnosis of congenital chloride diarrhea: a case report.

Authors:  Dae Hyung Lee; Yoon Ki Park
Journal:  J Obstet Gynaecol Res       Date:  2012-05-08       Impact factor: 1.730

9.  Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome.

Authors:  Rosa Vargas-Poussou; Chunfa Huang; Philippe Hulin; Pascal Houillier; Xavier Jeunemaître; Michel Paillard; Gabrielle Planelles; Michèle Déchaux; R Tyler Miller; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

10.  Congenital chloride diarrhea misdiagnosed as pseudo-Bartter syndrome.

Authors:  Hossein Saneian; Emad Bahraminia
Journal:  J Res Med Sci       Date:  2013-09       Impact factor: 1.852

View more
  4 in total

Review 1.  Diagnostic Challenge of Congenital Chloride Diarrhea and Ulcerative Colitis Overlap in an Adult Misdiagnosed with Bartter Syndrome: Case Report and Literature Review.

Authors:  Laila Fahad Sadagah; Ahmad Zaid Makeen; Eman Talal Kotbi
Journal:  Am J Case Rep       Date:  2022-07-05

2.  Functional characterization of SLC26A3 c.392C>G (p.P131R) mutation in intestinal barrier function using CRISPR/CAS9-created cell models.

Authors:  Nini Zhang; Daniel P Heruth; Weibin Wu; Li Qin Zhang; Marianne N Nsumu; Katherine Shortt; Kelvin Li; Xun Jiang; Baoxi Wang; Craig Friesen; Ding-You Li; Shui Qing Ye
Journal:  Cell Biosci       Date:  2019-05-14       Impact factor: 7.133

3.  Monogenic mutations in four cases of neonatal-onset watery diarrhea and a mutation review in East Asia.

Authors:  Weihui Yan; Yongtao Xiao; Yunyi Zhang; Yijing Tao; Yi Cao; Kunhui Liu; Wei Cai; Ying Wang
Journal:  Orphanet J Rare Dis       Date:  2021-09-09       Impact factor: 4.123

Review 4.  Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians.

Authors:  Laura Nuñez-Gonzalez; Noa Carrera; Miguel A Garcia-Gonzalez
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.